Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Experts Offer Clarity on Confusion Surrounding Stents


Related Encyclopedia
 border=
Alzheimer's Disease
Aneurysms
Angina Pectoris
Angiogram
More...

Related Healthscout Videos
 border=
The On-X Valve PROACT Trial
The On-X Heart Valve: Longevity With Less Reliance on Coumadin
Tissue Valves vs. Mechanical Valves
What is the difference between heart valve repair and replacement?
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Coronary Bypass Surgery
Erectile Dysfunction
More...

Related Drug Information
 border=
Accupril
Actonel
Altace
Avapro
More...

Related News Articles
 border=
Healthy Heart Tips for a Bad Economy
FDA: Company Knowingly Shipped Tainted Peanut Products
Needed: Blood Donations
Gene Therapy May Ease Rheumatoid Arthritis
More...


Page:  << Prev | 1 | 2 | 3 | 4 | Next >>

Some patients will still receive bare-metal stents in certain scenarios, he noted. These would include people whose arteries are simply the wrong size for a drug-coated stent, for example. In other cases, patients may need to avoid the excess bleeding risk that comes with a year or more of anti-coagulant therapy.

"This would include patients who are expected to need some surgical procedure in the next few months -- maybe they want a hip replacement or they have a tumor that needs to be removed," Garratt said. "We don't want then to implant a product that requires them to stay on dual anti-platelet drugs for an extended period of time if we know that that is coming."

For these types of reasons, bare-metal stents still make up 40 percent of the coronary stent market, said Dr. Charles Davidson, director of the cardiac catheterization laboratory at Northwestern Memorial Hospital, in Chicago.

Text Continues Below



When it comes to drug-eluting stents, the Taxus and Cypher models perform equally well, he said.

"I think they are very similar," Davidson said. "There's different drugs, different polymers, platforms. But if you look at the long-term clinical results and the short-term clinical results, they're very similar."

Many of the studies that have pitted the Taxus stent against its rival, Cypher, have been funded by the makers of either one of the devices, Davidson added. Patients should "not put too much stock into what's been out in the press, some of which may have been biased in one direction or another, for whatever reason," he said.

Instead, patients may want to focus on the steps they can take to ensure a long healthy life after receiving a stent.

"The most important thing that patients need to be aware of is that the anti-platelet therapy that is prescribed them by their physician needs to be adhered to," Davidson said. All too often, he said, patients either stop taking the anti-clotting drugs on their own or on the advice of a doctor who may not realize the patient has recently received a stent.

Page:  << Prev | 1 | 2 | 3 | 4 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 2/22/2008

Related Links
 border=
From Healthscout's partner site on heart disease, MyHeartCentral.com
Learn about heart disease symptoms.
Get more information on heart disease treatment for your health!
What can you do to prevent heart disease? Prevention details here.





SOURCES: Kirk Garratt, M.D., associate director, division of cardiac intervention, and clinical director, interventional cardiovascular research, Heart Vascular Institute, Lenox Hill Hospital, New York City; Charles Davidson, M.D., director, cardiac catheterization laboratory, Northwestern Memorial Hospital, Chicago


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map